menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Mario Biazzi’s Legacy In Nitroglycerin & Dipharma Group History

    GLOBENEWSWIRE

    Dipharma Granted CADIFA By ANVISA For Ursodeoxycholic Acid

    PRESS RELEASE

    Dipharma Attends XXVIII Italian Chemical Society Congress

    PRESS RELEASE

    Dipharma & Flow Chemistry: Lesson at University, CNR, and Industry Meeting

    PRESS RELEASE

    API Production: Technology Transfer and Troubleshooting Management

    PRESS RELEASE

    ISOS 2024: Dipharma Sponsors with Key Poster Presentation

    PRESS RELEASE

    Dipharma Francis Appoints New Board Of Directors

    PRESS RELEASE

    Dipharma contributes to the U.S. Life Sciences 2024 publication

    PRESS RELEASE

    Pharma Tech Outlook awards Dipharma as one of the Top CMOs in 2024

    PRESS RELEASE

    Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA

    GLOBENEWSWIRE

    Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA

    GLOBENEWSWIRE

    Dipharma expands its Italian R&D Center to increase its analytical services

    GLOBENEWSWIRE

    Dipharma Expands Italian R&D Center to Increase Analytical Services

    CONTRACT PHARMA

    Dipharma Completes Second Phase of CGMP Expansion at Kalamazoo Site

    CONTRACT PHARMA

    Dipharma completes second phase of CGMP expansion at its Kalamazoo site

    GLOBENEWSWIRE

    Dipharma`s Sapropterin Receives Approval in the Europe

    EMA

    Dipharma’s New Production Line Approved by the Italian Medicines Agency

    CONTRACTPHARMA

    Dipharma Receives Regulatory Authorization for New Line at Its cGMP Pilot Plant

    BUSINESSWIRE

    Dipharma B.V.`s Generic Sapropterin Hydrochloride Receives Approval in Europe

    EMA

    EffRx Pharma introduces Miglustat Dipharma 100 mg capsules in Switzerland

    PHARMABIZ

    Dipharma Francis S.r.l. Announces Changes in the Leadership Positions

    BUSINESSWIRE

    Dipharma Francis S.r.l. Enters into Agreement to Acquire Kalexsyn Inc.

    BUSINESSWIRE

    Dipharma Francis divests Malta-based subsidiary, Amino Chemicals ABA Chemicals

    PHARMABIZ

    Dipharma Announces Successful development of a stable, fast dissolving tablet Formulation of carglumic acid

    PRESS RELEASE

    Dipharma announces the validation of disanit® (nitisinone) marketing authorization application in Europe

    PRESS RELEASE

    Dipharma & Alvogen announce launch of Diterin® 100mg tablets in South Korea

    PRESS RELEASE

    AMERIGEN and DIPHARMA announce first regulatory submission for Miglustat 100mg Capsules

    PR NEWSWIRE

    AMERIGEN and DIPHARMA announce first regulatory submission for Miglustat

    PR NEWS WIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.